14th Oct 2020 10:20
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) | Barclays PLC. | |
Company dealt in | WILLIS TOWERS WATSON PLC | |
Class of relevant security to which the | ORD | |
dealings being disclosed relate (Note 2) | ||
Date of dealing | 13 October 2020 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Class of relevant security: | ORD | ||||
Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) | Relevant securities | ||||
2,567,145 | 1.99% | 467,804 | 0.36% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
412,656 | 0.32% | 388,524 | 0.30% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
purchase/sell: | 0 | 0.00% | 0 | 0.00% | |
|
|
|
| ||
TOTAL: |
|
|
|
| |
2,979,801 | 2.31% | 856,328 | 0.66% |
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
|
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 74 | 213.1695 USD |
Purchase | 87 | 212.8800 USD |
Purchase | 89 | 212.6613 USD |
Purchase | 100 | 214.1200 USD |
Purchase | 100 | 212.9600 USD |
Purchase | 100 | 212.7600 USD |
Purchase | 100 | 212.8200 USD |
Purchase | 101 | 212.8700 USD |
Purchase | 110 | 212.9100 USD |
Purchase | 123 | 212.8796 USD |
Purchase | 200 | 212.9450 USD |
Purchase | 286 | 212.8680 USD |
Purchase | 312 | 216.5200 USD |
Purchase | 400 | 212.9250 USD |
Purchase | 400 | 214.7500 USD |
Purchase | 422 | 213.3137 USD |
Purchase | 572 | 213.1729 USD |
Purchase | 600 | 216.4200 USD |
Purchase | 618 | 212.8864 USD |
Purchase | 683 | 213.0793 USD |
Purchase | 887 | 215.1489 USD |
Purchase | 914 | 212.9061 USD |
Purchase | 2,681 | 214.9595 USD |
Purchase | 2,785 | 215.5557 USD |
Purchase | 4,672 | 215.0246 USD |
Purchase | 4,732 | 212.5500 USD |
Purchase | 7,219 | 212.5510 USD |
Purchase | 10,634 | 213.6899 USD |
Purchase | 66,485 | 213.0892 USD |
Purchase | 66,485 | 213.0891 USD |
Sale | 4 | 213.9562 USD |
Sale | 4 | 212.9500 USD |
Sale | 23 | 212.9000 USD |
Sale | 100 | 213.8500 USD |
Sale | 122 | 216.0688 USD |
Sale | 182 | 214.1334 USD |
Sale | 200 | 216.9200 USD |
Sale | 200 | 213.6850 USD |
Sale | 200 | 213.6750 USD |
Sale | 204 | 213.8077 USD |
Sale | 258 | 212.7644 USD |
Sale | 269 | 214.1200 USD |
Sale | 300 | 213.7733 USD |
Sale | 312 | 216.5200 USD |
Sale | 320 | 213.7806 USD |
Sale | 600 | 216.4200 USD |
Sale | 680 | 214.2803 USD |
Sale | 683 | 213.0793 USD |
Sale | 737 | 212.8845 USD |
Sale | 813 | 214.4363 USD |
Sale | 1,023 | 213.0978 USD |
Sale | 1,252 | 213.0112 USD |
Sale | 1,389 | 212.8980 USD |
Sale | 1,493 | 212.9496 USD |
Sale | 1,500 | 214.1566 USD |
Sale | 1,796 | 213.0746 USD |
Sale | 1,819 | 213.8038 USD |
Sale | 2,072 | 215.8656 USD |
Sale | 2,300 | 213.0772 USD |
Sale | 2,310 | 213.1763 USD |
Sale | 2,585 | 215.4502 USD |
Sale | 2,898 | 212.8873 USD |
Sale | 2,939 | 213.0725 USD |
Sale | 3,603 | 213.5082 USD |
Sale | 3,665 | 215.1855 USD |
Sale | 4,159 | 213.1127 USD |
Sale | 5,141 | 213.1249 USD |
Sale | 5,800 | 213.6281 USD |
Sale | 7,518 | 213.8240 USD |
Sale | 11,943 | 212.5500 USD |
Sale | 30,304 | 212.8746 USD |
Sale | 66,485 | 213.0891 USD |
(b) Derivatives transactions (other than options transactions)
Product Name | Nature of transaction | Number of relevant securities | Price per |
|
| unit | |
SWAP | Long | 1 | 152,451,200.0000 USD |
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 (Open Positions) attached? | NO |
Date of disclosure: | 14 Oct 2020 |
Contact name: | Large Holdings Regulatory Operations |
Telephone number: | 020 3134 7213 |
If a connected EFM, name of offeree/offeror with which connected |
|
If a connected EFM, state nature of connection |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20201014005427/en/
Copyright Business Wire 2020
Related Shares:
Barclays